Leica Biosystems and Visikol to Host Multiplex Webinar
Visikol CEO Dr. Michael Johnson will be hosting a webinar with Leica Biosystems discussing multiplex imaging and the Leica [...]
Our Multiplex Immunolabeling Approach
Griffin Ferrara2021-02-03T15:56:14-05:00Immunohistochemistry is routinely used to localize and study the distribution of proteins in tissues. Most staining methods are limited [...]
Visikol Launches BitSlide, Cloud-Based Digital Pathology Slide Visualization Platform
Visikol has been a leader in advanced bioimaging through its portfolio of cutting-edge technologies and innovative drug discovery, bioimaging, [...]
Using Immunohistochemistry and Multiplex Slide Labeling for Tumor Research
Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues [...]
Visikol Expands Hampton Facility to Accommodate Service Growth
2020 was a challenging year for all industries and the life sciences field was no exception. Throughout 2020, Visikol [...]
New Year, New Services
Griffin Ferrara2021-01-08T15:14:13-05:00We are excited to finally turn the page on 2020 and get started on 2021 and are looking forward [...]
High Content Screening for Immune Modulators
Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. [...]
Advances in Immuno-oncology
Over the last decade there has been a boom of companies looking into immunotherapies for treating cancer [...]
Immuno-oncology Therapeutics and Drug Discovery
Immuno-oncology is an exciting field of research that is focused on developing therapeutics the leverage the immune system to [...]
Whole Mount Imaging: Ophthalmologic and Retina Studies
The retina is a vital sheet of nerve tissue at the back of the eye, transforming light signals into [...]